1. Home
  2. MTN vs CRSP Comparison

MTN vs CRSP Comparison

Compare MTN & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTN
  • CRSP
  • Stock Information
  • Founded
  • MTN 1997
  • CRSP 2013
  • Country
  • MTN United States
  • CRSP Switzerland
  • Employees
  • MTN N/A
  • CRSP N/A
  • Industry
  • MTN Services-Misc. Amusement & Recreation
  • CRSP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MTN Consumer Discretionary
  • CRSP Health Care
  • Exchange
  • MTN Nasdaq
  • CRSP Nasdaq
  • Market Cap
  • MTN 6.1B
  • CRSP 5.6B
  • IPO Year
  • MTN 1997
  • CRSP 2016
  • Fundamental
  • Price
  • MTN $152.46
  • CRSP $66.70
  • Analyst Decision
  • MTN Buy
  • CRSP Buy
  • Analyst Count
  • MTN 9
  • CRSP 18
  • Target Price
  • MTN $176.00
  • CRSP $73.47
  • AVG Volume (30 Days)
  • MTN 830.4K
  • CRSP 2.7M
  • Earning Date
  • MTN 12-08-2025
  • CRSP 11-04-2025
  • Dividend Yield
  • MTN 5.83%
  • CRSP N/A
  • EPS Growth
  • MTN 23.64
  • CRSP N/A
  • EPS
  • MTN 7.53
  • CRSP N/A
  • Revenue
  • MTN $2,964,347,000.00
  • CRSP $38,050,000.00
  • Revenue This Year
  • MTN $2.72
  • CRSP N/A
  • Revenue Next Year
  • MTN $3.48
  • CRSP $388.50
  • P/E Ratio
  • MTN $20.24
  • CRSP N/A
  • Revenue Growth
  • MTN 2.74
  • CRSP N/A
  • 52 Week Low
  • MTN $129.85
  • CRSP $30.04
  • 52 Week High
  • MTN $199.45
  • CRSP $78.48
  • Technical
  • Relative Strength Index (RSI)
  • MTN 51.40
  • CRSP 49.56
  • Support Level
  • MTN $148.51
  • CRSP $64.80
  • Resistance Level
  • MTN $152.85
  • CRSP $75.06
  • Average True Range (ATR)
  • MTN 4.50
  • CRSP 4.72
  • MACD
  • MTN 0.07
  • CRSP -0.88
  • Stochastic Oscillator
  • MTN 53.23
  • CRSP 14.40

About MTN Vail Resorts Inc.

Vail Resorts Inc Bhd is a resorts and casinos company that operates mountain resorts and ski areas. The company has three business segments that include Mountain, Lodging, and Real Estate. The Mountain segment operates numerous ski resort properties that offer a variety of winter and summer activities, such as skiing, snowboarding, snowshoeing, hiking, and mountain biking. The Lodging segment owns and operates hotels and condominiums. The Real Estate segment owns, develops, and leases real estate, typically near its other properties. The company generates the vast majority of its revenue within the United States.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: